---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-015792"
form_type: "8-K"
ticker: "ABEO"
cik: "0000318306"
company_name: "ABEONA THERAPEUTICS INC."
filed_at: "2024-04-24T23:59:59+00:00"
generated_at: "2026-06-03T09:56:15.833460+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Abeona shareholders approve equity plan increase to 3.2M shares; re-elect two directors

## Summary
- A&R 2023 Equity Incentive Plan approved, increasing shares reserved from 1.7M to 3.2M (1.5M new shares).
- Leila Alland and Vishwas Seshadri re-elected as Class 2 directors with overwhelming support.
- Advisory vote on named executive officer compensation approved: 9,529,727 for, 402,844 against.
- Ratification of Deloitte & Touche as independent auditor for FY2024 approved: 14,720,159 for.

## SEC filing metadata
- accession: 0001493152-24-015792
- form_type: 8-K
- ticker: ABEO
- cik: 0000318306
- company_name: ABEONA THERAPEUTICS INC.
- filed_at: 2024-04-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/318306/000149315224015792/0001493152-24-015792-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/318306/000149315224015792/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-015792
- JSON: https://secwatch.observer/filing/0001493152-24-015792.json
- Plain text: https://secwatch.observer/filing/0001493152-24-015792.txt

## Key facts
- Shareholder Votes
  ABEONA THERAPEUTICS INC. shareholders approved Election of Directors at the 2024-04-24 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-04-24
  source text: Leila Alland and Vishwas Seshadri were elected to serve as Class 2 directors of the Company until the 2027 annual meeting of stockholders and until their successors are elected and qualified. The results of the election of directors are as follows: Nominee Votes Non-Votes Leila Alland 8,985,852 958,122 12,938 5,093,839 Vishwas Seshadri 9,922,210 21,390 13,312 5,093,839
  evidence_url: https://www.sec.gov/Archives/edgar/data/318306/000149315224015792/0001493152-24-015792-index.htm
- Shareholder Votes
  ABEONA THERAPEUTICS INC. shareholders approved Ratification of the Appointment of Deloitte & Touche LLP as our Independent Registered Public Accounting Firm at the 2024-04-24 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-04-24
  source text: A proposal to ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024 was approved by the following votes: Votes Non-Votes 14,720,159 136,942 193,650 —
  evidence_url: https://www.sec.gov/Archives/edgar/data/318306/000149315224015792/0001493152-24-015792-index.htm
- Shareholder Votes
  ABEONA THERAPEUTICS INC. shareholders approved Approval of an Increase in the Number of Shares Reserved for Issuance Under the A&R Plan at the 2024-04-24 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2024-04-24
  source text: A proposal to approve an increase in the number of shares reserved for issuance under the A&R Plan from 1,700,000 to 3,200,000 shares was approved based on the following votes: Votes Non-Votes 9,358,912 570,314 27,686 5,093,839
  evidence_url: https://www.sec.gov/Archives/edgar/data/318306/000149315224015792/0001493152-24-015792-index.htm
- Shareholder Votes
  ABEONA THERAPEUTICS INC. shareholders approved Advisory Vote on Compensation of Named Executive Officers at the 2024-04-24 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2024-04-24
  source text: An advisory vote to approve the compensation of the Company’s named executive officers was approved by the following votes: Votes Non-Votes 9,529,727 402,844 24,341 5,093,839
  evidence_url: https://www.sec.gov/Archives/edgar/data/318306/000149315224015792/0001493152-24-015792-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.